Global Prothrombin Complex Market Research Report 2021
Table of Content
1 Prothrombin Complex Market Overview
- 1.1 Product Overview and Scope of Prothrombin Complex
- 1.2 Prothrombin Complex Segment by Type
- 1.2.1 Global Prothrombin Complex Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 500 IU/Vial
- 1.2.3 600 IU/Vial
- 1.2.4 1000 IU/Vial
- 1.2.5 Others
- 1.3 Prothrombin Complex Segment by Application
- 1.3.1 Prothrombin Complex Sales Comparison by Application: (2021-2027)
- 1.3.2 Hemophilia B
- 1.3.3 Vitamin K Deficiency
- 1.3.4 Others
- 1.4 Global Prothrombin Complex Market Size Estimates and Forecasts
- 1.4.1 Global Prothrombin Complex Revenue 2016-2027
- 1.4.2 Global Prothrombin Complex Sales 2016-2027
- 1.4.3 Prothrombin Complex Market Size by Region: 2016 Versus 2021 Versus 2027
2 Prothrombin Complex Market Competition by Manufacturers
- 2.1 Global Prothrombin Complex Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Prothrombin Complex Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Prothrombin Complex Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Prothrombin Complex Manufacturing Sites, Area Served, Product Type
- 2.5 Prothrombin Complex Market Competitive Situation and Trends
- 2.5.1 Prothrombin Complex Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Players Market Share by Revenue
- 2.5.3 Global Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prothrombin Complex Retrospective Market Scenario by Region
- 3.1 Global Prothrombin Complex Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.2 Global Prothrombin Complex Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.3 North America Prothrombin Complex Market Facts & Figures by Country
- 3.3.1 North America Prothrombin Complex Sales by Country
- 3.3.2 North America Prothrombin Complex Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Prothrombin Complex Market Facts & Figures by Country
- 3.4.1 Europe Prothrombin Complex Sales by Country
- 3.4.2 Europe Prothrombin Complex Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Prothrombin Complex Market Facts & Figures by Region
- 3.5.1 Asia Pacific Prothrombin Complex Sales by Region
- 3.5.2 Asia Pacific Prothrombin Complex Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Prothrombin Complex Market Facts & Figures by Country
- 3.6.1 Latin America Prothrombin Complex Sales by Country
- 3.6.2 Latin America Prothrombin Complex Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Prothrombin Complex Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Prothrombin Complex Sales by Country
- 3.7.2 Middle East and Africa Prothrombin Complex Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 U.A.E
4 Global Prothrombin Complex Historic Market Analysis by Type
- 4.1 Global Prothrombin Complex Sales Market Share by Type (2016-2021)
- 4.2 Global Prothrombin Complex Revenue Market Share by Type (2016-2021)
- 4.3 Global Prothrombin Complex Price by Type (2016-2021)
5 Global Prothrombin Complex Historic Market Analysis by Application
- 5.1 Global Prothrombin Complex Sales Market Share by Application (2016-2021)
- 5.2 Global Prothrombin Complex Revenue Market Share by Application (2016-2021)
- 5.3 Global Prothrombin Complex Price by Application (2016-2021)
6 Key Companies Profiled
- 6.1 Takeda
- 6.1.1 Takeda Corporation Information
- 6.1.2 Takeda Description and Business Overview
- 6.1.3 Takeda Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 Takeda Product Portfolio
- 6.1.5 Takeda Recent Developments/Updates
- 6.2 CSL
- 6.2.1 CSL Corporation Information
- 6.2.2 CSL Description and Business Overview
- 6.2.3 CSL Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 CSL Product Portfolio
- 6.2.5 CSL Recent Developments/Updates
- 6.3 Grifols
- 6.3.1 Grifols Corporation Information
- 6.3.2 Grifols Description and Business Overview
- 6.3.3 Grifols Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 Grifols Product Portfolio
- 6.3.5 Grifols Recent Developments/Updates
- 6.4 Octapharma
- 6.4.1 Octapharma Corporation Information
- 6.4.2 Octapharma Description and Business Overview
- 6.4.3 Octapharma Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Octapharma Product Portfolio
- 6.4.5 Octapharma Recent Developments/Updates
- 6.5 Hualan Biological
- 6.5.1 Hualan Biological Corporation Information
- 6.5.2 Hualan Biological Description and Business Overview
- 6.5.3 Hualan Biological Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 Hualan Biological Product Portfolio
- 6.5.5 Hualan Biological Recent Developments/Updates
- 6.6 Meheco Xinxing Pharma
- 6.6.1 Meheco Xinxing Pharma Corporation Information
- 6.6.2 Meheco Xinxing Pharma Description and Business Overview
- 6.6.3 Meheco Xinxing Pharma Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Meheco Xinxing Pharma Product Portfolio
- 6.6.5 Meheco Xinxing Pharma Recent Developments/Updates
7 Prothrombin Complex Manufacturing Cost Analysis
- 7.1 Prothrombin Complex Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Prothrombin Complex
- 7.4 Prothrombin Complex Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Prothrombin Complex Distributors List
- 8.3 Prothrombin Complex Customers
9 Prothrombin Complex Market Dynamics
- 9.1 Prothrombin Complex Industry Trends
- 9.2 Prothrombin Complex Growth Drivers
- 9.3 Prothrombin Complex Market Challenges
- 9.4 Prothrombin Complex Market Restraints
10 Global Market Forecast
- 10.1 Prothrombin Complex Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Prothrombin Complex by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Prothrombin Complex by Type (2022-2027)
- 10.2 Prothrombin Complex Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Prothrombin Complex by Application (2022-2027)
- 10.2.2 Global Forecasted Revenue of Prothrombin Complex by Application (2022-2027)
- 10.3 Prothrombin Complex Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Prothrombin Complex by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Prothrombin Complex by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Description
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma